image
Recursion Pharmaceuticals, Inc. RXRX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 5.03
-1.57 %
$ 2.01 B
Market Cap
-2.79
P/E
Price Target Average
102.78%
Revenue Forecast Estimate
48.91%
EBIT Estimate
25.98%
Net Income Estimate
17.48%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Recursion Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for RXRX of $10.2 , with forecasts ranging from a low of $6 to a high of $16 .
RXRX Lowest Price Target Wall Street Target
6 USD 19.28%
RXRX Average Price Target Wall Street Target
10.2 USD 102.78%
RXRX Highest Price Target Wall Street Target
16 USD 218.09%
Price
Max Price Target
Min Price Target
Average Price Target
161614141212101088664422Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart RXRX

image
$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.02021202120222022202320232024202420252025202620262027202720282028
EBIT FORECAST

EBIT Forecast Chart RXRX

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)($450.0m)($450.0m)($500.0m)($500.0m)2021202120222022202320232024202420252025202620262027202720282028
NET INCOME FORECAST

Net Income Chart RXRX

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)($450.0m)($450.0m)($500.0m)($500.0m)2021202120222022202320232024202420252025202620262027202720282028